HALOZYME THERAPEUTICS INC shareholders Q3 2023

HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 64 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Wellesley Asset Management 128,679,626$110,468,0065.49%
CAMDEN ASSET MANAGEMENT L P /CA 77,223,000$65,160,7672.42%
Penn Mutual Asset Management, LLC 1,555,000$1,312,1091.23%
ZAZOVE ASSOCIATES LLC 9,108,000$7,715,0000.80%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 50,000,000$42,190,0000.67%
Laffer Tengler Investments, Inc. 2,399$2,032,8230.60%
SHENKMAN CAPITAL MANAGEMENT INC 9,019,000$7,767,6720.58%
LINDEN ADVISORS LP 62,930,000$53,329,4250.55%
SSI INVESTMENT MANAGEMENT LLC 4,577,000$3,862,0740.32%
Sonora Investment Management Group, LLC 4,355,000$3,675,0600.31%
TENOR CAPITAL MANAGEMENT Co., L.P. 12,000,000$10,188,2160.22%
ADVENT CAPITAL MANAGEMENT /DE/ 6,769,000$5,745,5270.13%
Union Investments & Development Ltd. 200,000$169,4000.09%
WOLVERINE ASSET MANAGEMENT LLC 9,500,000$8,045,2850.09%
Lombard Odier Asset Management (Europe) Ltd 1,778,000$1,507,0150.08%
AVIVA PLC 21,000,000$17,716,9230.08%
PALISADE CAPITAL MANAGEMENT, LP 2,768,000$2,342,6310.06%
Daiwa Securities Group Inc. 3,882,000$3,2960.02%
LAZARD ASSET MANAGEMENT LLC 17,806,000$15,1130.02%
Calamos Advisors LLC 4,580,000$3,879,3060.02%

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q3 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.